Clinical Trial Detail

NCT ID NCT03573947
Title Phase II Clinical Trial of NIVO-IPI-TAXANE in Untreated Metastatic NSCLC (TOP1705)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Jeffrey Clarke
Indications

lung non-small cell carcinoma

Therapies

Ipilimumab + Nivolumab + Paclitaxel

Age Groups: adult senior

No variant requirements are available.